Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Synthetic Biologics- Inc. (SYN)

0.204 -0.008 (-3.77%)

07-19 16:00

Open:

0.213

Pre. Close:

0.212

High:

0.2188

Low:

0.2022

Volume:

229,765

Market Cap:

26M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.22 - 0.222

0.222 - 0.223

Low:

0.197 - 0.199

0.199 - 0.2

Close:

0.208 - 0.21

0.21 - 0.212

Technical analysis  (as of: 2018-07-19 4:33:15 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 0.28     One year: 0.30

Support:

Support1: 0.20    Support2: 0.17

Resistance:

Resistance1: 0.24    Resistance2: 0.26

Pivot:

0.22

Moving Averages:

MA(5): 0.21     MA(20): 0.22

MA(100): 0.28     MA(250): 0.50

MACD:

MACD(12,26): -0.01     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 18.28     %D(3): 19.06

RSI:

RSI(14): 43.61

52-Week:

High: 1.05  Low: 0.19  Change(%): -59.1

Average Vol(K):

3-Month: 61135  10-Days 48575

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SYN has closed above bottom band by 31.8%. Bollinger Bands are 59.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to SYN's normal range. The bands have been in this narrow range for 45 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-22T07:00:00-04:00
Synthetic Biologics Announces Acceptance of Compliance Plan by NYSE American

2018-05-08T21:37:06-04:00
Synthetic Biologics' (SYN) Management on Q1 2018 Results - Earnings Call Transcript

2018-05-08T16:05:00-04:00
Synthetic Biologics Reports First Quarter 2018 Operational Highlights and Financial Results

2018-04-26T07:00:00-04:00
Synthetic Biologics to Report First Quarter 2018 Operational Highlights and Financial Results on May 8, 2018

2018-04-24T03:11:01-04:00
Biotech Analysis Central Pharma News: Synthetic Loses Designation, Sage Files NDA , Alnylam Gets Positive Opinion From EMA

2018-04-23T07:00:00-04:00
Synthetic Biologics Provides Update on Development of SYN-004 (ribaxamase), for the Prevention of C. difficile Infection

2018-03-09T13:19:31-05:00
Homology Medicines Files For U.S. IPO

2018-03-07T16:10:00-05:00
Synthetic Biologics Reports on NYSE American Noncompliance Notice and Compliance Plan

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

128.57

Shares Float (M)

123.05

% Held by Insiders

4.30

% Held by Institutions

26.10

Shares Short (K)

3554

Shares Short Prior Month (K)

Stock Financials

EPS

-0.170

EPS Est. Current Year

-0.170

EPS Est. Next Year

-0.250

EPS Est. Next Quarter

-0.050

Forward EPS

1.#IO

Book Value (p.s.)

21.960

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-143.5

Return on Equity (ttm)

7022.7

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.095

Qtrly Earnings Growth

Operating Cash Flow (M)

-20.27

Levered Free Cash Flow (M)

-20.03

atoplab.com

Valuation

P/E

-1.25

P/E Growth Ratio

0.01

P/BV

0.01

P/S

P/CF

-1.35

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.